We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 4,028 results
  1. CGRP as a potential mediator for the sexually dimorphic responses to traumatic brain injury

    Background

    The outcomes of traumatic brain injury (TBI) exhibit variance contingent upon biological sex. Although female sex hormones exert...

    Chunyan Li, Erum Ajmal, ... David LeDoux in Biology of Sex Differences
    Article Open access 30 May 2024
  2. Monoclonal Antibody Targeting CGRP Relieves Cisplatin-Induced Neuropathic Pain by Attenuating Neuroinflammation

    Chemotherapy-induced neuropathic pain (CIPN) is a common side effect of antitumor chemotherapeutic agents. It describes a pathological state of pain...

    Shun Xie, Zhenfang Gao, ... Taiqian Gong in Neurotoxicity Research
    Article 09 January 2024
  3. Pharmaceutical aspects of novel CGRP inhibitors used in the prophylaxis and treatment of migraine

    Migraine is one of the most prevalent neurological disorders known to have an immense adverse socio-economic impact. Neurogenic inflammation is...

    Sandhya Jinesh in Inflammopharmacology
    Article 08 July 2023
  4. Expression of CGRP in the Trigeminal Ganglion and Its Effect on the Polarization of Macrophages in Rats with Temporomandibular Arthritis

    Calcitonin gene-related peptide (CGRP) is synthesized and secreted by trigeminal ganglion neurons, and is a key neuropeptide involved in pain and...

    Junli Tao, Xiaohui Wang, Jie Xu in Cellular and Molecular Neurobiology
    Article Open access 16 February 2024
  5. The neuropeptide CGRP enters the macrophage cytosol to suppress the NLRP3 inflammasome during pulmonary infection

    The NLRP3 inflammasome plays an essential role in resistance to bacterial infection. The nervous system secretes multiple neuropeptides affecting the...

    Fangrui Zhu, Dou Yu, ... Pengyan Xia in Cellular & Molecular Immunology
    Article 05 January 2023
  6. Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study

    Introduction

    Migraine usually ameliorates after menopause. However, 10–29% of women still experience migraine attacks after menopause, especially if...

    Simona Guerzoni, Carlo Baraldi, ... Luca Pani in Acta Neurologica Belgica
    Article 03 March 2023
  7. The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine

    Remarkable advancements have been made in the field of migraine pathophysiology and pharmacotherapy over the past decade. Understanding the molecular...

    Fred Cohen, Hsiangkuo Yuan, ... Stephen D. Silberstein in Neurotherapeutics
    Article 14 April 2022
  8. Acetaldehyde via CGRP receptor and TRPA1 in Schwann cells mediates ethanol-evoked periorbital mechanical allodynia in mice: relevance for migraine

    Background

    Ingestion of alcoholic beverages is a known trigger of migraine attacks. However, whether and how ethanol exerts its pro-migraine action...

    Lorenzo Landini, Daniel Souza Monteiro de Araujo, ... Francesco De Logu in Journal of Biomedical Science
    Article Open access 26 April 2023
  9. Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale

    Calcitonin gene-related peptide (CGRP), a 37 amino-acid neuropeptide found mostly in peptidergic sensory C-fibers, has been suggested to be...

    Fred Cohen, Hsiangkuo Yuan, Stephen D. Silberstein in BioDrugs
    Article 27 April 2022
  10. CGRP inhibits human Langerhans cells infection with HSV by differentially modulating specific HSV-1 and HSV-2 entry mechanisms

    Herpes simplex virus (HSV) is widespread globally, with both HSV-1 and HSV-2 responsible for genital herpes. During sexual transmission, HSV targets...

    Emmanuel Cohen, Jammy Mariotton, ... Yonatan Ganor in Mucosal Immunology
    Article 13 May 2022
  11. Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis

    In migraine patients with a poor response to a calcitonin gene-related peptide monoclonal antibody against the receptor, switching to a calcitonin...

    Giorgio Lambru, Valeria Caponnetto, ... Anna P. Andreou in Neurotherapeutics
    Article Open access 10 July 2023
  12. N/OFQ modulates orofacial pain induced by tooth movement through CGRP-dependent pathways

    Background

    Nociceptin/orphanin FQ (N/OFQ) has been revealed to play bidirectional roles in orofacial pain modulation. Calcitonin gene-related peptide...

    Xinyu Yan, Han Han, ... Wenli Lai in BMC Neuroscience
    Article Open access 09 April 2021
  13. Effect of Cholecystokinin-8 (CCK-8) on Blood Pressure and Blood Content of Calcitonin-Gene-Related Peptide (CGRP) in Rats with Hypertension Caused by Fructose or Inhibition of Nitric Oxide Synthesis

    We studied the effect of CCK-8 on BP and blood content of CGRP in rats with hypertension caused by fructose or inhibition of NO synthase with L-NAME....

    Z. S. Tolochko, V. K. Spiridonov in Bulletin of Experimental Biology and Medicine
    Article 01 September 2021
  14. CGRP-Mediated Prolactin Upregulation: a Possible Pathomechanism in IgG4-Related Disease

    Similar to other immune-mediated diseases, IgG4-related disease (IgG4-RD) is the disease that develops in genetically susceptible individuals exposed...

    Qicai Liu, Yunfeng Lin, ... Feng Gao in Inflammation
    Article 16 October 2020
  15. Antibody-Based Biotherapeutics in Migraine

    Migraine is a common, chronic, primary headache disorder characterized by attacks of headache and accompanying symptoms, with a significant personal...
    Willebrordus Petrus Johannes van Oosterhout in Pharmaceutical Biotechnology
    Chapter 2024
  16. Exogenous CGRP Regulates Apoptosis and Autophagy to Alleviate Traumatic Brain Injury Through Akt/mTOR Signalling Pathway

    With millions of traumatic brain injury (TBI) patients every year, TBI is regarded as one of the leading causes of human death and disability....

    Jun Tian, Lei Yang, ... Zhenzeng Fan in Neurochemical Research
    Article 15 October 2020
  17. AMPK/MTOR/TP53 Signaling Pathway Regulation by Calcitonin Gene-Related Peptide Reduces Oxygen-Induced Lung Damage in Neonatal Rats through Autophagy Promotion

    Our previous studies indicated that calcitonin gene-related peptide (CGRP) alleviates hyperoxia-induced lung injury and suggested the possible...

    Shaohua Wang, Zhengzhuang Zou, ... Jian Deng in Inflammation
    Article 19 March 2024
  18. The effect of lacosamide on calcitonin gene-related peptide serum level in episodic migraine patients: a randomized, controlled trial

    Background

    Migraine affects 11–15% of people worldwide, and the calcitonin gene-related peptide (CGRP) is released during the migraine attack,...

    Shimaa Elgamal, Sherihan Rezk Ahmed, ... Mohamed G. Zeinhom in Acta Neurologica Belgica
    Article Open access 19 March 2024
  19. Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System

    Introduction

    Anti-calcitonin gene-related peptide monoclonal antibodies (anti-CGRP-mAbs) have recently been approved for the prevention of migraine,...

    Emanuela Elisa Sorbara, Maria Antonietta Barbieri, ... Edoardo Spina in BioDrugs
    Article 25 February 2024
Did you find what you were looking for? Share feedback.